Search results for: Emerging Markets
Filter search results
Spotlight on OHE: Assessing Value and Balancing Needs in Health Care
15 December 2011
…Markets Health Care Systems, an OHE publication, and the NBER paper on pharmaceutical pricing in emerging markets, co-authored by Towse, Danzon and Mulcahy. [1] Gutacker, N., Bojke, C., Daidone, S.,…
Forecasting the Challenges and Economics of Drug Development in 2022
9 July 2013
…cases. For policy makers, the demographics of ageing make innovation in financing essential. 4. Innovation and markets will be truly global as demand evolves in emerging markets and as new…
A Final MVAC Blueprint—and the Start of an R&D Revolution?
6 February 2020
…for innovative products in emerging markets. We are proposing first use of this mechanism for new drugs for TB. Everyone agrees that the cost of inaction on TB is unacceptable;…
Insights From 2022 and Emerging Issues in 2023
7 December 2022, 12:00am
…the role of real-world evidence in supporting this. 2023 emerging issues: From sustainability to digital health technologies, this final presentation will explore the major policy issues OHE predict to lead…
Drugs and Vaccines for Developing Countries
1 June 2011
…in emerging markets are investing resources in innovative solutions for neglected diseases as they strive to evolve from generic producers into R&D-based companies. Government and philanthropic funding increase product availability…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
…the coming UK VBP system and reviewed evidence of the impact of existing VBP mechanisms in other countries. HTA in emerging markets was the focus of a satellite symposium at…
Pricing Variations Within and Across Countries: Gauging Efficiency
25 February 2014
…P., Mulcahy, A. & Towse, A., 2013. Pharmaceutical pricing in emerging markets: effects of income, competition, and procurement. Health Economics. [Online]. DOI: 10.1002/hec.3013. (For a more comprehensive summary of an…
Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico
4 January 2017
…A., Devlin, N., Hawe, E. & Garrison, L., 2011. The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response, London: Office of Health Economics….
OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare
15 June 2020
OHE authors develop a supply and demand model of pharmaceutical markets to analyse the social welfare distribution between consumers (payers) and developers (industry) to set an optimal cost-effectiveness threshold (CET)….